OCULAR IMMUNOLOGY AND UVEITIS FOUN… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2004

Legal Domicile

Principal Officer

SCOTT EVANS

Phone

6174613933

Tax Period

2024-01-01 to 2024-12-31

OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION, founded in 2004, is a community nonprofit in the Medical Research sector that reported $1.6M in total revenue in fiscal year 2024. The organization ran a surplus of $859K, a strong 55% operating margin.

Mission

THE OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION IS DEDICATED TO IMPROVING THE DIAGNOSIS AND TREATMENT AND FINDING THE CAUSES AND CURES OF UVEITIS AND OTHER OCULAR INFLAMMATORY DISEASES, INCREASE AWARENESS OF UVEITIS AMOUNG HEALTH PROFESSIONALS AND THE PUBLIC, AND SUPPORT INDIVIDUALS AND FAMILIES AFFECTED BY THE DISEASE.

Program Service Accomplishments

Program 1

Expenses: $123,381

VARIOUS RESEARCH STUDIES AND DEVELOPMENT TO PROMOTE AND CARRY OUT SCIENTIFIC AND MEDICAL RESEARCH IN THE FIELD OF DISEASES OF THE EYE.

Program 2

Expenses: $267,600 Revenue: $40,000

PHYSICIAN EDUCATION CONFERENCE: A COMPREHENSIVE COVERAGE OF NEW AND EMERGING DEVELOPMENTS IN THE SUBSPECIALTIES OF CORNEA, GLAUCOMA, CATARACT & REFRACTIVE SURGERY, OCULOPLASTICS, UVEITIS AND...

PHYSICIAN EDUCATION CONFERENCE: A COMPREHENSIVE COVERAGE OF NEW AND EMERGING DEVELOPMENTS IN THE SUBSPECIALTIES OF CORNEA, GLAUCOMA, CATARACT & REFRACTIVE SURGERY, OCULOPLASTICS, UVEITIS AND INFECTIOUS DISEASE. THE FACULTY CONSISTED OF NINETEEN OPHTHALMOLOGISTS. PHYSICIANS FROM ALL OVER NEW ENGLAND ATTENDED THE CONFERENCE.

Program 3

Expenses: $56,847

SUPPORT GROUP PROGRAMS, CONSISTS GENERALLY OF GROUP SPEAKERS, EDUCATIONAL AND SUPPORT RESOURCES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $1,307,421

Program Service Revenue $0

Investment Income $123,939

Other Revenue $134,427

TOTAL REVENUE $1,565,787

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $185,973

Program Expenses $447,828

Other Expenses $706,796

TOTAL EXPENSES $706,796

Year-over-Year Comparison

	2024	2023	Change
Revenue	$1,565,787	$1,638,698	0.0%
Expenses	$706,796	$704,660	+0.0%
Net Income	$858,991	$934,038	-0.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DR STEPHEN FOSTER	FOUNDER AND PRESIDENT EMERITUS	8.00	Officer Director	$0	$0	$0
SCOTT EVANS	TREASURER	5.00	Officer Director	$0	$0	$0
PETER NETLAND MD	DIRECTOR	0.00	Director	$0	$0	$0
DR DAVID S CHU	PRESIDENT	0.00	Officer Director	$0	$0	$0
ANDREA PATISTEAS	VICE CHAIR	0.00	Officer Director	$0	$0	$0
DR ALBERT T VITALE	DIRECTOR	0.00	Director	$0	$0	$0
MICHAEL ACHO	DIRECTOR	0.00	Director	$0	$0	$0
DR STEPHEN ANESI	DIRECTOR	0.00	Director	$0	$0	$0
DR PETER CHANG	DIRECTOR	0.00	Director	$0	$0	$0
CATHERINE POWERS	DIRECTOR	0.00	Director	$0	$0	$0
DR RAJIV SHAH	CLERK	0.00	Officer Director	$0	$0	$0
LUIS GONZALEZ MD	DIRECTOR	0.00	Director	$0	$0	$0
FRANCES FOSTER	DIRECTOR	0.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$1,565,787	$706,796	$3,006,646	$858,991
2023	$1,638,698	$704,660	$2,230,654	$934,038
2022	$733,623	$733,858	$1,079,830	$-235
2021	$675,565	$650,691	$1,297,410	$24,874
2020	$534,488	$551,435	$1,197,037	$-16,947
2019	$614,602	$780,636	$1,097,493	$-166,034
2018	$1,182,559	$1,458,358	$1,318,319	$-275,799

OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION